Eventide Asset Management - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 175 filers reported holding XENON PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$14,139,029
-11.3%
413,9060.0%0.25%
-5.6%
Q2 2023$15,935,381
-30.6%
413,906
-35.4%
0.27%
-36.1%
Q1 2023$22,948,548
-9.2%
641,2000.0%0.42%
-15.6%
Q4 2022$25,282,516
+9.2%
641,2000.0%0.50%
+9.7%
Q3 2022$23,147,000
+62.0%
641,200
+36.5%
0.46%
+48.7%
Q2 2022$14,288,000
-48.5%
469,700
-68.5%
0.31%
-18.0%
Q2 2021$27,744,000
+4.0%
1,490,0000.0%0.37%
-5.6%
Q1 2021$26,671,000
+68.3%
1,490,000
+44.6%
0.40%
+62.6%
Q4 2020$15,844,000
+12.3%
1,030,140
-19.1%
0.24%
-12.0%
Q3 2020$14,104,000
-11.7%
1,274,1000.0%0.28%
-20.5%
Q2 2020$15,977,000
+10.6%
1,274,1000.0%0.35%
-25.9%
Q1 2020$14,448,000
-13.5%
1,274,1000.0%0.47%
-0.6%
Q4 2019$16,703,000
+45.5%
1,274,1000.0%0.47%
+24.3%
Q3 2019$11,480,000
-8.6%
1,274,1000.0%0.38%
-0.8%
Q2 2019$12,563,000
+99.2%
1,274,100
+105.3%
0.38%
+76.0%
Q1 2019$6,306,000
+135.5%
620,691
+46.2%
0.22%
+82.4%
Q4 2018$2,678,000
-35.6%
424,433
+34.7%
0.12%
-22.2%
Q3 2018$4,158,000315,0000.15%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 790,000$12,071,0003.53%
GREAT POINT PARTNERS LLC 700,000$10,696,0002.49%
COMMODORE CAPITAL LP 579,432$8,854,0002.33%
ACUTA CAPITAL PARTNERS, LLC 417,409$6,378,0002.25%
DAFNA Capital Management LLC 406,535$6,212,0001.65%
Tri Locum Partners LP 264,134$4,036,0001.60%
Parkman Healthcare Partners LLC 311,207$4,755,0001.20%
Ghost Tree Capital, LLC 250,000$3,820,0001.12%
Nan Fung Group Holdings Ltd 197,880$3,024,0000.97%
BVF INC/IL 1,571,778$24,017,0000.94%
View complete list of XENON PHARMACEUTICALS INC shareholders